Universal Health Services Surpasses 200-Day Moving Average - Positive Outlook for UHS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 20 2025
0mins
Source: NASDAQ.COM
UHS Stock Performance: UHS's stock has a 52-week low of $152.33 and a high of $243.25, with the last trade recorded at $184.11.
Source of Information: The data regarding UHS's stock performance was sourced from Technical Analysis Channel.com.
Dividend Stocks Update: There is an indication that other dividend stocks have recently crossed above their 200-day moving average.
Author's Opinion Disclaimer: The views expressed in the article are those of the author and do not necessarily reflect the opinions of Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UHS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UHS
Wall Street analysts forecast UHS stock price to rise
15 Analyst Rating
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 156.630
Low
190.00
Averages
248.00
High
302.00
Current: 156.630
Low
190.00
Averages
248.00
High
302.00
About UHS
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company, UHS of Delaware, Inc. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include Acute Care Hospital Services and Behavioral Health Care Services. It owns and operates approximately 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources as well as a variety of management services to our facilities, including central purchasing, information services, finance and control systems, among others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Universal Health Services to Present at Goldman Sachs Healthcare Conference
- Conference Schedule: Universal Health Services is set to present at the Goldman Sachs Annual Global Healthcare Conference on June 9, 2026, at 8:00 AM ET, highlighting its leadership in the healthcare sector.
- Live Webcast: The presentation will be available via a live audio webcast and replay on the company's Investor Relations section of its website, ensuring investors have timely access to important information.
- Company Overview: Universal Health Services is one of the largest and most respected providers of hospital and healthcare services in the U.S., operating acute care hospitals, behavioral health facilities, and ambulatory centers across the United States, the United Kingdom, and Puerto Rico.
- Industry Impact: As a prominent player in the healthcare services industry, Universal Health Services plays a crucial role in enhancing the quality and accessibility of healthcare services, further solidifying its market position.
See More
Universal Health Services Announces Cash Dividend
- Dividend Announcement: Universal Health Services' Board of Directors has voted to pay a cash dividend of $0.20 per share on June 18, 2026, to shareholders of record as of June 8, 2026, reflecting the company's commitment to shareholder returns and aiming to bolster investor confidence.
- Business Scale: As one of the largest providers of hospital and healthcare services in the U.S., UHS operates acute care hospitals, behavioral health facilities, and outpatient services across the United States, Puerto Rico, and the United Kingdom, ensuring its leadership position in the healthcare sector.
- Shareholder Return Strategy: This cash dividend not only indicates the company's stable financial condition but also demonstrates its ongoing focus on shareholder interests, potentially attracting more investor attention to its stock and enhancing market performance.
- Future Outlook: With the continuous growth in healthcare demand, UHS's efforts to expand its service network and improve healthcare quality will provide strong support for its future profitability and shareholder value creation.
See More
Paramount Plans to Release 30 Films Annually
- Release Commitment: Paramount CEO David Ellison promised at CinemaCon to release 30 films annually, although this ambitious goal has raised skepticism within the industry, especially post-merger with Warner Bros., which is expected to present greater production and distribution challenges.
- Merger Impact Analysis: Ellison's plan hinges on regulatory approval for the merger with Warner Bros., yet historical data indicates that past mergers often lead to fewer releases, prompting industry experts to express concerns that the 30-film target is overly ambitious.
- Market Response and Challenges: While theater operators are skeptical about the feasibility of such a high output due to insufficient quality IP support, AMC CEO Adam Aron has expressed support for the merger, believing it will help expand film distribution.
- Industry Status and Future: Post-pandemic, theaters are struggling with a lack of new titles; although 2023 has seen an increase in film releases, the anticipated reduction in output following a merger could further impact box office revenues, leaving the industry's outlook pessimistic.
See More
UNIVERSAL HEALTH SERVICES INC: TD COWEN LOWERS TARGET PRICE FROM $245 TO $230
Price Reduction Announcement: Universal Health Services has announced a price cut for its services, reducing the target price from $245 to $230.
Impact on Stakeholders: This price adjustment may affect various stakeholders, including patients, investors, and healthcare providers, as it reflects changes in the company's service pricing strategy.
See More
Universal Health Services Q1 2026 Earnings Call Insights
- Acquisition Strategy: UHS announced the acquisition of Talkspace, which is expected to be accretive to earnings within the first 12 months post-closing, and by year three, the effective EBITDA multiple for the Talkspace transaction is projected to be in the single-digit range, indicating the company's potential for expansion in the behavioral health sector.
- Financial Performance: In Q1 2026, UHS reported net income of $5.65 per share and adjusted EPS of $5.62, with a revenue growth rate of 9.6%, demonstrating the company's ability to maintain robust operational performance despite seasonal challenges.
- AI Implementation: UHS has deployed eight different AI solutions into its revenue cycle operations, significantly enhancing operational efficiency; while management noted it is too early to project the long-term financial impact of these initiatives in 2026, short-term benefits are already being realized.
- Shareholder Returns: The company repurchased 675,000 shares at a total cost of $127 million in Q1 and plans to continue share repurchases throughout 2026, reflecting a strong commitment to shareholder returns.
See More
Universal Health Services Q1 Earnings Exceed Expectations
- Earnings Beat: Universal Health Services reported a Q1 non-GAAP EPS of $5.62, surpassing expectations by $0.16, which underscores the company's robust profitability in the healthcare sector and strengthens its market position.
- Significant Revenue Growth: The company achieved Q1 revenue of $4.49 billion, reflecting a 9.5% year-over-year increase and exceeding market expectations by $100 million, indicating successful market share expansion amid rising healthcare demand.
- Attractive Valuation: With a price-to-earnings ratio of 8x compared to HCA's 16x, Universal Health Services presents a compelling investment opportunity that may attract value investors and potentially drive stock price appreciation.
- Acquisition Strategy: The acquisition of Talkspace signifies a strategic shift towards hybrid healthcare models, aiming to enhance customer experience and competitive positioning through the integration of digital health services.
See More
Universal Health Services to Present at Goldman Sachs Healthcare Conference
- Conference Schedule: Universal Health Services is set to present at the Goldman Sachs Annual Global Healthcare Conference on June 9, 2026, at 8:00 AM ET, highlighting its leadership in the healthcare sector.
- Live Webcast: The presentation will be available via a live audio webcast and replay on the company's Investor Relations section of its website, ensuring investors have timely access to important information.
- Company Overview: Universal Health Services is one of the largest and most respected providers of hospital and healthcare services in the U.S., operating acute care hospitals, behavioral health facilities, and ambulatory centers across the United States, the United Kingdom, and Puerto Rico.
- Industry Impact: As a prominent player in the healthcare services industry, Universal Health Services plays a crucial role in enhancing the quality and accessibility of healthcare services, further solidifying its market position.
See More
Universal Health Services Announces Cash Dividend
- Dividend Announcement: Universal Health Services' Board of Directors has voted to pay a cash dividend of $0.20 per share on June 18, 2026, to shareholders of record as of June 8, 2026, reflecting the company's commitment to shareholder returns and aiming to bolster investor confidence.
- Business Scale: As one of the largest providers of hospital and healthcare services in the U.S., UHS operates acute care hospitals, behavioral health facilities, and outpatient services across the United States, Puerto Rico, and the United Kingdom, ensuring its leadership position in the healthcare sector.
- Shareholder Return Strategy: This cash dividend not only indicates the company's stable financial condition but also demonstrates its ongoing focus on shareholder interests, potentially attracting more investor attention to its stock and enhancing market performance.
- Future Outlook: With the continuous growth in healthcare demand, UHS's efforts to expand its service network and improve healthcare quality will provide strong support for its future profitability and shareholder value creation.
See More
Paramount Plans to Release 30 Films Annually
- Release Commitment: Paramount CEO David Ellison promised at CinemaCon to release 30 films annually, although this ambitious goal has raised skepticism within the industry, especially post-merger with Warner Bros., which is expected to present greater production and distribution challenges.
- Merger Impact Analysis: Ellison's plan hinges on regulatory approval for the merger with Warner Bros., yet historical data indicates that past mergers often lead to fewer releases, prompting industry experts to express concerns that the 30-film target is overly ambitious.
- Market Response and Challenges: While theater operators are skeptical about the feasibility of such a high output due to insufficient quality IP support, AMC CEO Adam Aron has expressed support for the merger, believing it will help expand film distribution.
- Industry Status and Future: Post-pandemic, theaters are struggling with a lack of new titles; although 2023 has seen an increase in film releases, the anticipated reduction in output following a merger could further impact box office revenues, leaving the industry's outlook pessimistic.
See More
UNIVERSAL HEALTH SERVICES INC: TD COWEN LOWERS TARGET PRICE FROM $245 TO $230
Price Reduction Announcement: Universal Health Services has announced a price cut for its services, reducing the target price from $245 to $230.
Impact on Stakeholders: This price adjustment may affect various stakeholders, including patients, investors, and healthcare providers, as it reflects changes in the company's service pricing strategy.
See More
Universal Health Services Q1 2026 Earnings Call Insights
- Acquisition Strategy: UHS announced the acquisition of Talkspace, which is expected to be accretive to earnings within the first 12 months post-closing, and by year three, the effective EBITDA multiple for the Talkspace transaction is projected to be in the single-digit range, indicating the company's potential for expansion in the behavioral health sector.
- Financial Performance: In Q1 2026, UHS reported net income of $5.65 per share and adjusted EPS of $5.62, with a revenue growth rate of 9.6%, demonstrating the company's ability to maintain robust operational performance despite seasonal challenges.
- AI Implementation: UHS has deployed eight different AI solutions into its revenue cycle operations, significantly enhancing operational efficiency; while management noted it is too early to project the long-term financial impact of these initiatives in 2026, short-term benefits are already being realized.
- Shareholder Returns: The company repurchased 675,000 shares at a total cost of $127 million in Q1 and plans to continue share repurchases throughout 2026, reflecting a strong commitment to shareholder returns.
See More
Universal Health Services Q1 Earnings Exceed Expectations
- Earnings Beat: Universal Health Services reported a Q1 non-GAAP EPS of $5.62, surpassing expectations by $0.16, which underscores the company's robust profitability in the healthcare sector and strengthens its market position.
- Significant Revenue Growth: The company achieved Q1 revenue of $4.49 billion, reflecting a 9.5% year-over-year increase and exceeding market expectations by $100 million, indicating successful market share expansion amid rising healthcare demand.
- Attractive Valuation: With a price-to-earnings ratio of 8x compared to HCA's 16x, Universal Health Services presents a compelling investment opportunity that may attract value investors and potentially drive stock price appreciation.
- Acquisition Strategy: The acquisition of Talkspace signifies a strategic shift towards hybrid healthcare models, aiming to enhance customer experience and competitive positioning through the integration of digital health services.
See More
